Aguiar Talita Ferreira Marques, Rivas Maria Prates, de Andrade Silva Edson Mario, Pires Sara Ferreira, Dangoni Gustavo Dib, Macedo Taiany Curdulino, Defelicibus Alexandre, Barros Bruna Durães de Figueiredo, Novak Estela, Cristofani Lilian Maria, Odone Vicente, Cypriano Monica, de Toledo Silvia Regina Caminada, da Cunha Isabela Werneck, da Costa Cecilia Maria Lima, Carraro Dirce Maria, Tojal Israel, de Oliveira Mendes Tiago Antonio, Krepischi Ana Cristina Victorino
Department of Genetics and Evolutionary Biology, Institute of Biosciences, Human Genome and Stem-Cell Research Center, University of São Paulo, São Paulo, Brazil.
Columbia University Irving Medical Center, New York, NY, USA.
Biochem Genet. 2024 Apr 22. doi: 10.1007/s10528-024-10764-y.
Hepatoblastoma stands as the most prevalent liver cancer in the pediatric population. Characterized by a low mutational burden, chromosomal and epigenetic alterations are key drivers of its tumorigenesis. Transcriptome analysis is a powerful tool for unraveling the molecular intricacies of hepatoblastoma, shedding light on the effects of genetic and epigenetic changes on gene expression. In this study conducted in Brazilian patients, an in-depth whole transcriptome analysis was performed on 14 primary hepatoblastomas, compared to control liver tissues. The analysis unveiled 1,492 differentially expressed genes (1,031 upregulated and 461 downregulated), including 920 protein-coding genes (62%). Upregulated biological processes were linked to cell differentiation, signaling, morphogenesis, and development, involving known hepatoblastoma-associated genes (DLK1, MEG3, HDAC2, TET1, HMGA2, DKK1, DKK4), alongside with novel findings (GYNG4, CDH3, and TNFRSF19). Downregulated processes predominantly centered around oxidation and metabolism, affecting amines, nicotinamides, and lipids, featuring novel discoveries like the repression of SYT7, TTC36, THRSP, CCND1, GCK and CAMK2B. Two genes, which displayed a concordant pattern of DNA methylation alteration in their promoter regions and dysregulation in the transcriptome, were further validated by RT-qPCR: the upregulated TNFRSF19, a key gene in the embryonic development, and the repressed THRSP, connected to lipid metabolism. Furthermore, based on protein-protein interaction analysis, we identified genes holding central positions in the network, such as HDAC2, CCND1, GCK, and CAMK2B, among others, that emerged as prime candidates warranting functional validation in future studies. Notably, a significant dysregulation of non-coding RNAs (ncRNAs), predominantly upregulated transcripts, was observed, with 42% of the top 50 highly expressed genes being ncRNAs. An integrative miRNA-mRNA analysis revealed crucial biological processes associated with metabolism, oxidation reactions of lipids and carbohydrates, and methylation-dependent chromatin silencing. In particular, four upregulated miRNAs (miR-186, miR-214, miR-377, and miR-494) played a pivotal role in the network, potentially targeting multiple protein-coding transcripts, including CCND1 and CAMK2B. In summary, our transcriptome analysis highlighted disrupted embryonic development as well as metabolic pathways, particularly those involving lipids, emphasizing the emerging role of ncRNAs as epigenetic regulators in hepatoblastomas. These findings provide insights into the complexity of the hepatoblastoma transcriptome and identify potential targets for future therapeutic interventions.
肝母细胞瘤是儿童群体中最常见的肝癌。其特点是突变负担低,染色体和表观遗传改变是其肿瘤发生的关键驱动因素。转录组分析是揭示肝母细胞瘤分子复杂性的有力工具,有助于了解遗传和表观遗传变化对基因表达的影响。在这项针对巴西患者开展的研究中,对14例原发性肝母细胞瘤及对照肝组织进行了深入的全转录组分析。分析发现了1492个差异表达基因(1031个上调和461个下调),其中包括920个蛋白质编码基因(占62%)。上调的生物学过程与细胞分化、信号传导、形态发生和发育相关,涉及已知的肝母细胞瘤相关基因(DLK1、MEG3、HDAC2、TET1、HMGA2、DKK1、DKK4)以及新发现的基因(GYNG4、CDH3和TNFRSF19)。下调的过程主要集中在氧化和代谢方面,影响胺类、烟酰胺和脂质,有一些新发现,如SYT7、TTC36、THRSP、CCND1、GCK和CAMK2B的抑制。有两个基因在其启动子区域显示出DNA甲基化改变和转录组失调的一致模式,通过RT-qPCR进一步验证:上调的TNFRSF19是胚胎发育中的关键基因,以及受抑制的THRSP与脂质代谢有关。此外,基于蛋白质-蛋白质相互作用分析,我们确定了在网络中占据中心位置的基因,如HDAC2、CCND1、GCK和CAMK2B等,这些基因成为未来研究中进行功能验证的主要候选基因。值得注意的是,观察到非编码RNA(ncRNA)存在显著失调,主要是上调的转录本,前50个高表达基因中有42%是ncRNA。综合miRNA-mRNA分析揭示了与代谢、脂质和碳水化合物的氧化反应以及甲基化依赖的染色质沉默相关的关键生物学过程。特别是,四个上调的miRNA(miR-186、miR-214、miR-377和miR-494)在网络中起关键作用,可能靶向多个蛋白质编码转录本,包括CCND1和CAMK2B。总之,我们的转录组分析突出了胚胎发育以及代谢途径的紊乱,特别是那些涉及脂质的途径,强调了ncRNA作为肝母细胞瘤表观遗传调节因子的新作用。这些发现为肝母细胞瘤转录组的复杂性提供了见解,并确定了未来治疗干预的潜在靶点。